Femasys (FEMY) Projected to Post Earnings on Thursday

Femasys (NASDAQ:FEMY) is expected to be posting its results before the market opens on Thursday, May 7th. Analysts expect Femasys to post earnings of ($0.0667) per share and revenue of $0.7670 million for the quarter.

Femasys (NASDAQ:FEMY) last released its earnings results on Tuesday, March 31st. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.07. The company had revenue of $0.81 million during the quarter, compared to analyst estimates of $1.06 million. Femasys had a negative return on equity of 534.94% and a negative net margin of 812.74%.

Femasys Price Performance

FEMY opened at $0.37 on Tuesday. The stock has a fifty day moving average of $0.48 and a 200-day moving average of $0.63. The firm has a market capitalization of $22.46 million, a P/E ratio of -0.74 and a beta of -2.26. Femasys has a 12-month low of $0.31 and a 12-month high of $1.22. The company has a quick ratio of 2.95, a current ratio of 4.53 and a debt-to-equity ratio of 0.89.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Weiss Ratings upgraded Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday. Lake Street Capital assumed coverage on shares of Femasys in a research report on Tuesday, March 3rd. They set a “buy” rating and a $1.50 target price on the stock. Finally, Wall Street Zen cut shares of Femasys from a “hold” rating to a “sell” rating in a research note on Saturday, March 28th. Four analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $5.50.

Institutional Trading of Femasys

Several hedge funds have recently modified their holdings of FEMY. Banco BTG Pactual S.A. acquired a new stake in shares of Femasys during the fourth quarter worth approximately $88,000. Geode Capital Management LLC increased its holdings in shares of Femasys by 50.8% during the fourth quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock worth $224,000 after buying an additional 131,052 shares in the last quarter. Jane Street Group LLC acquired a new stake in shares of Femasys during the fourth quarter worth approximately $62,000. Cetera Investment Advisers acquired a new stake in shares of Femasys during the fourth quarter worth approximately $36,000. Finally, HRT Financial LP acquired a new stake in shares of Femasys during the fourth quarter worth approximately $30,000. Institutional investors and hedge funds own 65.27% of the company’s stock.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.